Gen-X, situated in Amsterdam, the Netherlands, is a biotech company specializing in large-scale functional genome annotation using our innovative SuRE technology. Our expertise includes screening services for identifying and licensing DNA elements for gene therapy and recombinant protein production, as well as licensing DNA elements derived from our extensive R&D pipeline.